SIGAR suggests that the United States' ineffective policies and efforts to reduce opium cultivation in Afghanistan dramatically affected vulnerable populations who either grow or consume opium and continue to suffer immensely.
DPA suggests drug law enforcement disproportionately targets minority groups, specifically focusing on how it affects women, over men in the United States.
Research suggests that the stark increase in the risk of age-related methadone-specific deaths in UK, calls for administrators of the drug to alert their clients about a potential increased risk to their health as they age.
Tom Decorte offers a detailed model of what a regulated, non-profit cannabis market might look as more countries continue to legalise and decriminalise cannabis.
Annual EMCDDA report shows uptick in production and new supply channels, as the continent continues to grapple with overdose deaths and the challenges of NPS.
EMCDDA suggests new psychoactive drug usage is rapidly growing in prisons and may be causing further drug problems in federal facilities, a phenomenon in need of a widespread response by communities and policymakers.
This paper highlights the inadequacy of pbisilocyn's scheduling in the United States, pointing at its relatively low potential for abuse and substantial therapeutic potential.
HPA explores the advantages associated with a regulated Cannabis market and the potential benefits it could bring to public services in the UK, such as the NHS.
OSF explores the potential that the coca leaf holds and sets out the parameters for a system that could significantly expand coca industrialization in a manner that makes the most of its social, political, economic, and environmental benefits.
The EMCDDA aims to provide those concerned with policy developments in the field of cannabis with a brief overview of current knowledge and the latest developments in the area of driving.
The GDPO describe recent operations targeting crypto-drug markets, highlighting both the increased sophistication of law enforcement crackdowns and the enduring resilience of these markets.
The ECDC and the EMCDDA develop a common evidence-based guidance for the prevention and control of communicable diseases in prison settings in the EU/EEA.
